Practice parameters for hemodynamic support of sepsis in adult patients in sepsis: Task force of the american college of critical care medicine, society of critical care medicine

Critical Care Medicine

Volumn 27, Issue 3, 1999, Pages 639-660

  Hollenberg, Steven M ^a   Ahrens, Tom S ^a   Astiz, Mark E ^a   Chalfin, Donald B ^a   Dasta, Joseph F ^a   Heard, Stephen O ^a   Martin, Claude ^a   Susla, Gregory M ^a   Vincent, Jean Louis ^a  

^a NONE

Author keywords

Fluid resuscitation; Hemodynamic; Inotropic therapy; Sepsis; Septic shock; Vasopressor therapy

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; ISOPRENALINE; MILRINONE; NORADRENALIN; PHENYLEPHRINE;

ARTICLE; COLLOID; CRYSTALLOID; DRUG EFFICACY; DRUG MONITORING; EVIDENCE BASED MEDICINE; EXPERT SYSTEM; EXTRACORPOREAL OXYGENATION; FLUID THERAPY; HEMODYNAMIC MONITORING; INOTROPISM; INTENSIVE CARE; INTENSIVE CARE UNIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; TISSUE PERFUSION;

EID: 0032908255     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199903000-00049     Document Type: Article

References (197)

1. 1. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242
2. 2. Hollenberg SM, Parrillo JE: Shock. In: Harrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, et al (Eds). New York, McGraw-Hill, 1997, pp 214-222
3. 3. Rackow EC, Astiz ME: Mechanisms and management of septic shock. Crit Care Clin 1993; 9: 219-237
4. 4 (V). Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100: 483-490
5. 5. Astiz M, Rackow EC, Weil MH, et al: Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 1988; 26:311-320
6. 6. Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95:2S-4S
7. 7. Hotchkiss RS, Karl IE: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992; 267: 1503-1510
8. 8 (II). Hayes MA, Timmins AC, Yau EH, et al: Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 1997; 25:926-936
9. 9 (V). Steffes CP, Dahn MS, Lange MP: Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 1994; 129:46-52
10. 10 (V). Boekstegers P, Weidenhofer S, Pilz G, et al: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991; 5:317-323
11. 2 in endotoxemic dogs. J Appl Physiol 1989; 66:2553-2558
12. 12. Rackow E, Astiz ME, Weil MH: Increases in oxygen extraction during rapidly fatal septic shock in rats. J Lab Clin Med 1987; 109:660-664
13. 13. Gore DC, Jahoor F, Hibbert JM, et al: Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224:97-102
14. 14 (V). Friedman G, Berlot G, Kahn RJ: Combined measurements of blood lactate levels and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995; 23:1184-1193
15. 15 (V). Vincent JL, Dufaye P, Berre J: Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11:449-451
16. 16 (V). Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure. Circulation 1970; 41:989-1001
17. 17 (V). Bakker J, Coffemils M, Leon M, et al: Blood lactates are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1992; 99:956-962
18. 2 up-take during bacteremia in the dog. J Appl Physiol 1987; 63: 1487-1489
19. 2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998; 157:1219-1225
20. 20. Creteur J, De Backer D, Vincent JL: Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validation studies. Anesthesiology 1997; 87:504-510
21. 21. Russell JA: Gastric tonometry: Does it work? Intensive Care Med 1997; 23:3-6
22. 22 (V). Marik PE: Gastric intramucosal pH. A better predictor of multi-organ dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104:225-229
23. 23 (V). Maynard N, Bihari D, Beale R, et al: Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993; 270: 1203-1210
24. 24 (II). Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992; 339:195-199
25. 25 (V). Doglio GR, Pusajo JF, Egurrola MA, et al: Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991; 19:1037-1040
26. 26 (III). Packman MJ, Rackow EC: Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983; 11:165-169
27. 27 (V). Rackow EC, Falk JL, Fein IA: Fluid resuscitation in shock: A comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic shock. Crit Care Med 1983; 11:839-850
28. 28 (V). Conrad S, Dietch K, Hebert C: Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990; 31:419-429
29. 29 (V). Mink R, Pollack M: Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990; 18:1087-1091
30. 30 (V). Steffes C, Bender J, Levison M: Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med 1991; 19:512-517
31. 31 (V). Marik P, Sibbald W: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-3029
32. 32 (II). Tuchschmidt J, Fried J, Astiz M, et al: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216-220
33. 33 (II). Yu M, Levy MM, Smith P, et al: Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study. Crit Care Med 1993; 21:830-838
34. 34 (II). Hayes MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
35. 35 (I). Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032
36. 36 (II). Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993; 270:2699-2707
37. 37. Heyland DK, Cook DJ, King D, et al: Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med 1996; 24:517-524
38. 38 (II). Levy B, Bollaert PB, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23:282-287
39. 39 (II). Marik PE, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357
40. 40 (II). Schreuder WO, Schneider AJ, Groeneveld ABJ, et al: Effect of dopamine vs. norepinephrine on hemodynamics in septic shock. Chest 1989; 95:1282-1288
41. 41. Carroll G, Snyder J: Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 1982; 243:R131-R141
42. 42 (V). Rackow EC, Kaufman BS, Falk JL, et al: Hemodynamic response to fluid repletion in patient with septic shock: Evidence for early depression of cardiac performance. Circ Shock 1987; 22: 11-22
43. 43 (III). Winslow EJ, Loeb HS, Rahimtoola SH, et al: Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 1973; 54:421-432
44. 44. Greenfield LJ, Jackson RH, Elkins RC: Cardiopulmonary effects of volume loading of primates in endotoxin shock. Surgery 1974; 76:560-570
45. 45 (V). Weil MH, Nishjima H: Cardiac output in bacterial shock. Am J Med 1978; 64:920-923
46. 46 (III). Haupt MT, Gilbert EM, Carlson RW: Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis 1985; 131:912-916
47. 47 (V). Sugerman H, Diaco J, Pollack T, et al: Physiologic management of septicemic shock in man. Surg Forum 1971; 22:3-5
48. 48 (V). Nelson A, Fleisher L, Roenbaum S: Relationship between postoperative anemia and cardiac morbidity in high risk vascular patients in the intensive care unit. Crit Care Med 1993; 21:860-866
49. 49. Morisaki H, Sibbald W, Martin C, et al: Hyperdynamic sepsis depresses the circulatory compensation of normovolemic anemia in conscious rats. J Appl Physiol 1996; 82:656-664
50. 50 (III). Silverman H, Tuma P: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red cell transfusion. Chest 1992; 102:184-189
51. 51 (II). Hebert P, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
52. 52 (III). Lamke LO, Liljedahl SO: Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976; 5:85-92
53. 53 (III). Shoemaker WC: Comparisons of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit Care Med 1976; 4:71-78
54. 54 (V). Boldt J, Muller M, Heesen M, et al: Influence of different volume therapies and pentoxifylline infusion on circulatory soluble adhesion molecules in critically ill patients. Crit Care Med 1996; 24:358-391
55. 55. Morisaki H, Bloos F, Keys J, et al: Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994; 77:1507-1518
56. 56 (II). Falk JL, Rackow EC, Astiz ML, et al: Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 1988; 28:412-415
57. 57. Schmand J, Ayala A, Morrison M, et al: Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased IL-6 levels. Crit Care Med 1995; 23:806-814
58. 58. Guyton AC, Lindsey AW: Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959; 7:649-657
59. 59. Kramer GC, Harms BA, Bodai BI, et al: Effects of hypoproteinemia and increased vascular pressure on lung fluid balance in sheep. J Appl Physiol 1983; 55:1514-1522
60. 60 (V). Rackow EC, Fein AI, Siegel J: The relationships of colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982; 82:433-437
61. 61 (V). Finley RJ, Holliday RL, Lefcoe M, et al: Pulmonary edema in patients with sepsis. Surg Gynecol Obstet 1975; 140:851-857
62. 62 (V). Sìse MJ, Shackford SR, Peters RM, et al: Serum oncotic-hydrostatic pressure differences in critically ill patients. Anesth Analg 1982; 61:496-498
63. 63 (II). Virgilio RW, Rice CL, Smith DE, et al: Crystalloid vs. colloid resuscitation. Is one better? A randomized clinical study. Surgery 1979; 85:129-139
64. 64 (II). Moss G, Lower R, Jilek J: Colloid or crystalloid in the resuscitation of hemorrhagic shock: A controlled clinical trial. Surgery 1981; 89:434-437
65. 65. Rackow EC, Astiz ME, Janz T, et al: Absence of pulmonary edema during peritonitis and shock in rats. J Lab Clin Med 1989; 112:264-269
66. 66. Nylander WAJ, Hammon JWJ, Roselli RJ, et al: Comparison of the effects of saline and homologous plasma infusion on lung fluid balance during endotoxemia in unanesthetized sheep. Surgery 1981; 90:221-228
67. 67 (II). Metildi LA, Shackford SR, Virgilio RW, et al: Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984; 158:207-212
68. 68 (V). Appel P, Shoemaker WC: Evaluation of fluid therapy in adult respiratory failure. Crit Care Med 1981; 9:862-869
69. 69. Baum TD, Wang H, Rothschild HR, et al: Mesenteric oxygen metabolism, ileal mucosal hydrogen ion concentration and tissue edema after crystalloid or colloid resuscitation in porcine endotoxic shock: Comparison of Ringer's lactate and 6% hetastarch. Circ Shock 1990; 30:385-397
70. 70. Rackow EC, Astiz ME, Schumer W, et al: Lung and muscle water after crystalloid and colloid infusion in septic rats: Effect on oxygen delivery and metabolism. J Lab Clin Med 1989; 113:184-189
71. 71. O'Brien R, Murdoch J, Kuehn R, et al: The effect of albumin or crystalloid resuscitation on bacterial translocation and endotoxin absorption following experimental burn injury. J Surg Res 1992; 52:161-166
72. 72. Rudis MI, Basha MA, Zarowitz BJ: Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 1996; 24:525-537
73. 73. Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995; 3:650-661
74. 74. Kirchheim HR, Ehmke H, Hackenthal E, et al: Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987; 410:441-449
75. 75 (V). Barry K, Mazze R, Schwarz F: Prevention of surgical oliguria and renal hemodynamic suppression by sustained hydration. N Engl J Med 1967; 270:1371-1377
76. 76 (V). Bush HL Jr, Huse JB, Johnson WC, et al: Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading. Arch Surg 1981; 116:1517-1524
77. 77. Kelleher SP, Robinette JB, Conger JD: Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 1984; 246:F379-F386
78. 78 (III). Martin C, Saux P, Eon B, et al: Septic shock: A goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990; 34:413-417
79. 79 (V). Hoffman MJ, Greenfield LJ, Sugerman HJ, et al: Unsuspected right ventricular dysfunction in shock and sepsis. Arch Surg 1983; 198:307-319
80. 80 (V). Martin C, Perrin G, Saux P, et al: Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 1994; 20:444-447
81. 81 (V). Vincent JL, Reuse C, Frank N, et al: Right ventricular dysfunction in septic shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 1989; 33: 34-38
82. 82 (V). Desjars P, Pinaud M, Tasseau F, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
83. 83 (V). Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
84. 84 (V). Bollaert PE, Bauer P, Audibert G, et al: Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98: 949-953
85. 85 (V). Fukuoka T, Nishimura M, Imanaka H, et al: Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989; 17:1104-1107
86. 86 (V). Hesselvik JF, Brodin B: Low dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989; 17:179-180
87. 87 (V). Lipman J, Roux A, Kraus P: Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991; 19:61-65
88. 88 (V). Martin C, Eon B, Saux P, et al: Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
89. 89 (V). Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-667
90. 90 (V). Redl-Wenzl EM, Armbruster C, Edelmann G, et al: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
91. 91 (V). Gregory JS, Bonfiglio MF, Dasta JF, et al: Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395-1400
92. 92 (V). Meier-Hellmann A, Bredle DL, Specht M, et al: The effects of low-dose dopamine on splanchnic blood flow and oxygen utilization in patients with septic shock. Intensive Care Med 1997; 23:31-37
93. 93 (III). Hannemann L, Reinhart K, Grenzer O, et al: Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23:1962-1970
94. 94 (III). Ruokonen E, Takala J, Kari A, et al: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
95. 95 (III). Jardin F, Gurdjian F, Desfonds P, et al: Effect of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit Care Med 1979; 7:273-277
96. 96 (III). Jardin F, Eveleigh MC, Gurdjian F, et al: Venous admixture in human septic shock. Comparative effects of blood volume expansion, dopamine infusion and isoproterenol infusion in mismatching of ventilation and pulmonary blood flow in peritonitis. Circulation 1979; 60:155-159
97. 97 (II). Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993; 103:1826-1831
98. 98 (II). Regnier B, Safran D, Carlet J, et al: Comparative haemodynamic effects of dopamine and dobutamine in septic shock. Intensive Care Med 1979; 5:115-120
99. 99 (V). Samii K, Le Gall JR, Regnier B, et al: Haemodynamic effects of dopamine in septic shock with and without acute renal failure. Arch Surg 1978; 113:1414-1416
100. 100 (V). Drueck C, Welch GW, Pruitt BA Jr: Hemodynamic analysis of septic shock in thermal injury: Treatment with dopamine. Am Surg 1978; 44:424-427
101. 101 (V). Regnier B, Rapin M, Gory G, et al: Hemodynamic effects of dopamine in septic shock. Intensive Care Med 1977; 3:47-53
102. 102 (V). Wilson RF, Sibbald WJ, Jaanimagi JL: Hemodynamic effects of dopamine in critically ill septic patients. J Surg Res 1976; 20:163-172
103. 103 (IV). Maynard ND, Bihari DJ, Dalton RN, et al: Increasing splanchnic blood flow in the critically ill. Chest 1995; 108:1648-1654
104. 104 (II). Neviere R, Mathieu D, Chagnon JL, et al: The contrasting effects of dobutamine and dopamine on mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996; 154:1684-1688
105. 105 (V). Wilson W, Lipman J, Scribante J, et al: Septic shock: Does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992; 20:470-474
106. 106 (III). Moran JL, O'Fathartaigh MS, Peisach AR, et al: Epinephrine as an inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993; 21:70-77
107. 107 (III). Mackenzie SJ, Kapadia F, Nimmo GR, et al: Adrenaline in treatment of septic shock: Effects on haemodynamics and oxygen transport. Intensive Care Med 1991; 17:36-39
108. 108 (V). Le Tulzo Y, Seguin P, Gacouin A, et al: Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary study. Intensive Care Med 1997; 23:664-670
109. 109 (II). Day NP, Phu NH, Bethell DP, et al: The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996; 348:219-223
110. 110 (III). Levy B, Bollaert PE, Lucchelli JP, et al: Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 1997; 25:1649-1654
111. 111. Chernow B, Roth BL: Pharmacologic manipulation of the peripheral vasculature in shock: Clinical and experimental approaches. Circ Shock 1986; 18:141-155
112. 112. Martin C, Yaghi A, Sibbald W, et al: Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 1993; 148:164-172
113. 113. Nelson L, Snyder J: Technical problems in data acquisition. In: Oxygen Transport in the Critically Ill. Vol 15. Snyder JV, Pinsky MR (Eds). Chicago, Year Book Medical Publishing, 1987, pp 205-234
114. 114 (V). Eckstein J, Abboud F: Circulation effect of sympathomimetic amines. Am Heart J 1962; 63:119-121
115. 115. Mills L, Moyer J, Handley C: Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 1960; 198: 1279-1284
116. 116. Murakawa K, Kobayashi A: Effects of vasopressors on renal tissue gas tensions during hemorrhagic shock in dogs. Crit Care Med 1988; 16:789-792
117. 117. Conger JD, Robinette JB, Guggenheim SJ: Effect of acetylcholine on the early phase of reversible norepinephrine-induced acute renal failure. Kidney Jnt 1981; 19:399-409
118. 118. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
119. 119 (V). Hoogenberg K, Smit AJ, Girbes ARJ: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998; 26:260-265
120. 120 (V). Reinelt H, Radermacher P, Fischer G, et al: Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997; 86:818-824
121. 121. Dasta JF: Norepinephrine in septic shock: Renewed interest in an old drug. DICP Ann Pharmacother 1990; 24:153-156
122. 122 (V). Moyer J, Skelton J, Mills L: Norepinephrine: Effect in normal subjects; use in treatment of shock unresponsive to other measures. Am J Med 1953; 15:330-343
123. 123 (V). Yamazaki T, Shimada Y, Taenaka N, et al: Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 1982; 10:432-435
124. 124 (III). Flancbaum L, Dick M, Dasta J, et al: A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997; 51:461-465
125. 125 (V). Parker M, Suffredini A, Natanson C, et al: Responses of left ventricular function in survivors and nonsurvivors of septic shock. J Crit Care 1989; 4:19-25
126. 126. Raper R, Sibbald M, Driedger A, et al: Relative myocardial depression in normotensive sepsis. J Crit Care 1989; 4:9-18
127. 127 (V). Parker MM, McCarthy K, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
128. 128 (V). Parker MM, Ognibene FP, Parrillo JE: Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock. Crit Care Med 1994; 22:1955-1959
129. 129 (V). Ognibene FP, Parker MM, Natanson C, et al: Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93:903-910
130. 130 (V). Dhainaut JF, Huyghebaert MF, Monsallier JF, et al: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987; 75:533-541
131. 131 (V). Cunnion RE, Schaer GL, Parker MM, et al: The coronary circulation in human septic shock. Circulation 1986; 73:637-644
132. 132. Gotloib L, Shostak A, Galdi P, et al: Loss of microvascular negative charges accompanied by interstitial edema in septic rats' heart. Circ Shock 1992; 36:45-56
133. 2+ transport. Mol Cell Biochem 1992; 112:135-142
134. 134. Bensard DD, Banerjee A, McIntyre RC Jr, et al: Endotoxin disrupts beta-adrenergic signal transduction in the heart. Arch Surg 1994; 129:198-204; discussion 204-205
135. 135. Carli A, Auclair MC, Vernimmen C: Indomethacin suppresses the early cardiodepressant factor released by endotoxin in the rat: Possible involvement of a prostacyclin-related material. Adv Shock Res 1983; 10:161-171
136. 136. Baum TD, Heard SO, Feldman HS, et al: Endotoxin-induced myocardial depression in rats: Effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist. J Surg Res 1990; 48:629-634
137. 137. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
138. 138. Brady AJB, Poole-Wilson PA, Harding SE, et al: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263:H1963-H1966
139. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105:575-580
140. 140 (III). Gilbert EM, Haupt MT, Mandanas RY, et al: The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986; 134:873-878
141. 141 (V). Ronco JJ, Fenwick JC, Tweeddale MG, et al: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724-1730
142. 142. Jain A, Shroff SG, Janicki JS, et al: Relation between mixed venous oxygen saturation and cardiac index. Nonlinearity and normalization for oxygen uptake and hemoglobin. Chest 1991; 99:1403-1409
143. 143 (V). Vaughn S, Puri VK: Cardiac output changes and continuous mixed venous oxygen saturation measurement in the critically ill. Crit Care Med 1988; 16:495-498
144. 144 (III). Weisbul JP, O'Donnell TFJ, Stone MA, et al: Myocardial performance in clinical septic shock: Effects of isoproterenol and glucose potassium insulin. J Surg Res 1975; 18:357-363
145. 145 (III). Loeb HS, Winslow EB, Rahimtoola SH, et al: Acute hemodynamic effects of dopamine in patients with shock. Circulation 1971; 44:163-173
146. 146 (III). Nasraway SA, Rackow EC, Astiz ME, et al: Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest 1989; 95:612-615
147. 147 (III). de la Cal MA, Miravalles E, Pascual T, et al: Dose-related hemodynamic and renal effects of dopamine in septic shock. Crit Care Med 1984; 12:22-25
148. 148 (V). Jardin F, Sportiche M, Bazin M, et al: Dobutamine: A hemodynamic evaluation in human septic shock. Crit Care Med 1981; 9:329-332
149. 149 (II). De Backer D, Berre J, Zhang H, et al: Relationship between oxygen uptake and oxygen delivery in septic patients: Effects of prostacyclin versus dobutamine. Crit Care Med 1993; 21:1658-1664
150. 150 (III). Vallet B, Chopin C, Curtis SE, et al: Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective, multicenter study. Crit Care Med 1993; 21:1868-1875
151. 151 (III). Gutierrez G, Clark C, Brown SD, et al: Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994; 150:324-329
152. 152 (III). De Backer D, Moraine JJ, Berre J, et al: Effects of dobutamine on oxygen consumption in septic patients. Direct versus indirect determinations. Am J Respir Crit Care Med 1994; 150:95-100
153. 153 (III). Ronco JJ, Fenwick JC, Wiggs BR, et al: Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993; 147:25-31
154. 154 (V). Vincent JL, Roman A, Kahn RJ: Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990; 18:689-693
155. 155 (III). Mira JP, Fabre JE, Baigorri F, et al: Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine. Chest 1994; 106:1524-1531
156. 156 (III). Redl-Wenzl EM, Armbruster C, Edelmann G, et al: Noradrenaline in the "high output-low resistance" state of patients with abdominal sepsis. Anaesthesist 1990; 39:525-529
157. 157 (V). Tell B, Majerus TC, Flancbaum L: Dobutamine in elderly septic shock patients refractory to dopamine. Intensive Care Med 1987; 13:14-18
158. 158 (II). Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109:1302-1312
159. 159 (V). Hannemann L, Reinhart K, Meier-Hellmann A, et al: Dopexamine hydrochloride in septic shock. Chest 1996; 109:756-760
160. 160 (V). Lund N, de Asla RJ, Cladis F, et al: Dopexamine hydrochloride in septic shock: Effects on oxygen delivery and oxygenation of gut, liver, and muscle. J Trauma 1995; 38:767-775
161. 161. Cain SM, Curtis SE: Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 1991; 19:1552-1560
162. 162. Cain SM, Curtis SE: Systemic and regional oxygen uptake and lactate flux in endotoxic dogs resuscitated with dextran and dopexamine or dextran alone. Circ Shock 1992; 38:173-181
163. 163. Palsson J, Ricksten SE, Houltz E, et al: Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand 1997; 41:392-398
164. 164. van Lambalgen AA, van Kraats AA, Mulder MF, et al: Organ blood flow and distribution of cardiac output in dopexamine-or dobutamine-treated endotoxemic rats. J Crit Care 1993; 8:117-127
165. 165 (V). Colardyn FC, Vandenbogaerde JF, Vogelaers DP, et al: Use of dopexamine hydrochloride in patients with septic shock. Crit Care Med 1989; 17:999-1003
166. 166 (III). Smithies M, Yee TH, Jackson L, et al: Protecting the gut and the liver in the critically ill: Effects of dopexamine. Crit Care Med 1994; 22:789-795
167. 167 (V). Vincent JL, Reuse C, Kahn RJ: Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest 1989; 96:1233-1236
168. 168. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-3064
169. 169 (V). Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
170. 170. Krafte-Jacobs B, Brilli R, Szabo C, et al: Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997; 25:1588-1593
171. 171. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993; 264:H660-H663
172. 172 (V). Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels inpatients after trauma and during sepsis. Ann Surg 1991; 214: 621-626
173. 173. Forstermann U, Schmidt HHHW, Pollock JS: Isoforms of nitric oxide synthase: Characterization and purification from different cell types. Biochem Pharmacol 1991; 42:1849-1856
174. 174. Gray G, Schott C, Julou-Schaeffer G, et al: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991; 103:1218-1244
175. G-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 20: S132-S134
176. 176. Freeman BD, Zeni F, Banks SM, et al: Response of the septic vasculature to prolonged vasopressor therapy with N-monomethyl-L-arginine and epinephrine in canines. Crit Care Med 1998; 26:877-886
177. 177 (II). Robertson FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129:149-156
178. 178 (V). Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1995; 28:34-39
179. 179 (V). Lorente JA, Landin L, De Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21:1287-1295
180. 180. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655
181. 181. Harbrecht BG, Billiar TR, Stadler J, et al: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992; 52:390-394
182. 182. Cobb JP, Natanson C, Hoffman WD, et al: N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176: 1175-1182
183. 183. Statman R, Cheng W, Cunningham JN, et al: Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 1994; 57:93-98
184. 184 (I). Grover R, Lopez A, Lorente J, et al: Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Abstr. Crit Care Med 1999; 27:A33
185. 185. Aranow JS, Zhuang J, Wang H, et al: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. Shock 1996; 5:116-121
186. 186 (V). Rouselet A, Feihl F, Markert M, et al: Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 1998; 158:162-170
187. 187 (III). Preiser JC, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23:259-264
188. 188. Stein B, Pfenninger E, Grunert A, et al: Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16: 494-499
189. 189. Grootendorst AF, van Bommel EF, van der Hoven B, et al: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18: 235-240
190. 190. Griffin MP, Zwischenberger JB, Minifee PK, et al: Extracorporeal membrane oxygenation for Gramnegative septic shock in the immature pig. Circ Shock 1991; 33:195-199
191. 191 (V). Bottoms G, Fessler J, Murphey E, et al: Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 1996; 5:149-154
192. 192 (V). Beca J, Butt W: Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 1994; 93:726-729
193. 193 (V). McCune S, Short BL, Miller MK, et al: Extracorporeal membrane oxygenation therapy in neonates with septic shock. J Pediatr Surg 1990; 25:479-482
194. 194 (V). Goldman AP, Kerr SJ, Butt W, et al: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466-469
195. 195 (V). Bellomo R, Tipping P, Boyce N: Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 1991; 37:M322-M323
196. 196 (V). Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21:522-526
197. 197 (V). Hoffmann JN, Hartl WH, Deppisch R, et al: Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48:1563-1570